Copyright Reports & Markets. All rights reserved.

Global Leber's Hereditary Optic Neuropathy Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global Leber's Hereditary Optic Neuropathy Drug Market Research Report 2018

      1 Leber's Hereditary Optic Neuropathy Drug Market Overview

      • 1.1 Product Overview and Scope of Leber's Hereditary Optic Neuropathy Drug
      • 1.2 Leber's Hereditary Optic Neuropathy Drug Segment by Type (Product Category)
        • 1.2.1 Global Leber's Hereditary Optic Neuropathy Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Leber's Hereditary Optic Neuropathy Drug Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Elamipretide
        • 1.2.3 GS-011
        • 1.2.5 IXC-201
        • 1.2.6 KH-176

      Others

      • 1.3 Global Leber's Hereditary Optic Neuropathy Drug Segment by Application
        • 1.3.1 Leber's Hereditary Optic Neuropathy Drug Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Leber's Hereditary Optic Neuropathy Drug Market by Region (2013-2025)
        • 1.4.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Leber's Hereditary Optic Neuropathy Drug (2013-2025)
        • 1.5.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Leber's Hereditary Optic Neuropathy Drug Capacity, Production Status and Outlook (2013-2025)

      2 Global Leber's Hereditary Optic Neuropathy Drug Market Competition by Manufacturers

      • 2.1 Global Leber's Hereditary Optic Neuropathy Drug Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Leber's Hereditary Optic Neuropathy Drug Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Leber's Hereditary Optic Neuropathy Drug Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Leber's Hereditary Optic Neuropathy Drug Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Leber's Hereditary Optic Neuropathy Drug Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Leber's Hereditary Optic Neuropathy Drug Market Competitive Situation and Trends
        • 2.5.1 Leber's Hereditary Optic Neuropathy Drug Market Concentration Rate
        • 2.5.2 Leber's Hereditary Optic Neuropathy Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Leber's Hereditary Optic Neuropathy Drug Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Leber's Hereditary Optic Neuropathy Drug Production and Market Share by Region (2013-2018)
      • 3.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Leber's Hereditary Optic Neuropathy Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption by Region (2013-2018)
      • 4.2 North America Leber's Hereditary Optic Neuropathy Drug Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Leber's Hereditary Optic Neuropathy Drug Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Leber's Hereditary Optic Neuropathy Drug Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Leber's Hereditary Optic Neuropathy Drug Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Leber's Hereditary Optic Neuropathy Drug Production, Consumption, Export, Import (2013-2018)

      5 Global Leber's Hereditary Optic Neuropathy Drug Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Leber's Hereditary Optic Neuropathy Drug Production and Market Share by Type (2013-2018)
      • 5.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2013-2018)
      • 5.4 Global Leber's Hereditary Optic Neuropathy Drug Production Growth by Type (2013-2018)

      6 Global Leber's Hereditary Optic Neuropathy Drug Market Analysis by Application

      • 6.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Leber's Hereditary Optic Neuropathy Drug Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Profiles/Analysis

      • 7.1 Alkeus Pharmaceuticals, Inc.
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Biovista Inc.
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 GenSight Biologics S.A.
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Ixchel Pharma, LLC
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Khondrion BV
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Spark Therapeutics, Inc.
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Stealth BioTherapeutics Inc.
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Leber's Hereditary Optic Neuropathy Drug Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview

      8 Leber's Hereditary Optic Neuropathy Drug Manufacturing Cost Analysis

      • 8.1 Leber's Hereditary Optic Neuropathy Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Leber's Hereditary Optic Neuropathy Drug Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Leber's Hereditary Optic Neuropathy Drug Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Leber's Hereditary Optic Neuropathy Drug Market Forecast (2018-2025)

      • 12.1 Global Leber's Hereditary Optic Neuropathy Drug Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Leber's Hereditary Optic Neuropathy Drug Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Leber's Hereditary Optic Neuropathy Drug Price and Trend Forecast (2018-2025)
      • 12.2 Global Leber's Hereditary Optic Neuropathy Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Leber's Hereditary Optic Neuropathy Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Leber's Hereditary Optic Neuropathy Drug Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Leber's Hereditary Optic Neuropathy Drug Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global Leber's Hereditary Optic Neuropathy Drug market status and forecast, categorizes the global Leber's Hereditary Optic Neuropathy Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

        The major manufacturers covered in this report
        Alkeus Pharmaceuticals, Inc.
        Biovista Inc.
        GenSight Biologics S.A.
        Ixchel Pharma, LLC
        Khondrion BV
        Spark Therapeutics, Inc.
        Stealth BioTherapeutics Inc.

        Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Elamipretide
        GS-011
        IXC-201
        KH-176
        Others
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Hospital
        Clinic
        Others

        The study objectives of this report are:
        To analyze and study the global Leber's Hereditary Optic Neuropathy Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
        Focuses on the key Leber's Hereditary Optic Neuropathy Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Leber's Hereditary Optic Neuropathy Drug are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Leber's Hereditary Optic Neuropathy Drug Manufacturers
        Leber's Hereditary Optic Neuropathy Drug Distributors/Traders/Wholesalers
        Leber's Hereditary Optic Neuropathy Drug Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Leber's Hereditary Optic Neuropathy Drug market, by end-use.
        Detailed analysis and profiles of additional market players.

        Buy now